Two builders who’ve spent their careers inside the supplement industry — from formulating products and running manufacturing lines to scaling brands and now, developing the proprietary ingredients that power them.
Kyle Armstrong is a formulation scientist and business strategist whose career has been defined by an obsessive commitment to getting the science right — and getting the product to market.
Kyle’s journey in the supplement industry began with Rejuvica Health, the direct-to-consumer supplement brand he co-founded with Kyle Dilger. At Rejuvica, Kyle led product development from the ground up — personally formulating each SKU, selecting raw materials, validating dosages against published clinical research, and overseeing production runs from prototype to commercial scale.
When Kyle and his co-founder launched Triton Nutra Group, Kyle brought his formulation expertise to a much larger stage. As a co-founder of the contract manufacturing operation, he worked directly with hundreds of brands — helping them translate product concepts into viable, manufacturable formulas.
At Hestia Bioscience, Kyle channels this deep formulation knowledge into proprietary ingredient development. He leads the company’s R&D pipeline, overseeing the scientific validation, clinical research partnerships, and formulation engineering behind every Hestia compound.
Kyle Dilger is a financial strategist and operations executive whose career has been built on a singular talent: turning ambitious ideas into scalable, profitable realities.
Kyle’s entry into the supplement industry came through Rejuvica Health, which he co-founded alongside Kyle Armstrong. While Armstrong drove the formulation science, Dilger architected the business — building the financial models, supply chain infrastructure, and operational systems that allowed Rejuvica to grow rapidly while maintaining product quality and margin integrity.
The launch of Triton Nutra Group showcased Kyle’s operational capabilities at a new level. As co-founder and financial lead, he was responsible for the capital strategy, facility buildout, regulatory compliance infrastructure, and day-to-day operations of a full-service cGMP manufacturing facility.
At Hestia Bioscience, Kyle oversees the company’s financial architecture, strategic partnerships, and operational infrastructure. He ensures that every ingredient Hestia develops isn’t just scientifically sound — it’s commercially viable, properly protected, and positioned for scalable licensing.
“We built brands. We ran the manufacturing lines. We scaled the operations. Hestia is everything we’ve learned, distilled into the most foundational thing in this industry — the ingredient itself.”